Fny Investment Advisers, LLC Arvinas, Inc. Transaction History

Fny Investment Advisers, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 10, 2022	SELL	$65.85 - $96.21 $45,634 - $66,673	-693 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$73.2 - $107.87 $50,727 - $74,753	693 New	693 $56,000
Q4 2018 Jan 22, 2019	SELL	$11.19 - $18.56 $14,547 - $24,128	-1,300 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$16.05 - $16.87 $20,865 - $21,931	1,300 New	1,300 $21,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.